Cinobufagin Suppresses the Characteristics of Osteosarcoma Cancer Cells by Inhibiting the IL-6-OPN-STAT3 Pathway [Retraction]

Abstract

Zhang C, Ma K, Li WY. Drug Des Devel Ther. 2019;13:4075–4090. The Editor and Publisher of Drug Design, Development and Therapy wish to retract the published article. The authors advised that errors were made in Figure 3A and they could not provide satisfactory original data that would validate the findings of their study. The Editor advised for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper

Keywords

• osteosarcoma
• cancer stem cells
• cinobufagin
• il-6-stat3 signaling pathway